Fortress Biotech, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Fortress Biotech, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Fortress Biotech, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 27.6M shares, a 209% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 27.6M +18.6M +209% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 22.6M -109M -82.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 19.4M -111M -85.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 15.1M +7.73M +105% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 8.94M -99.3M -91.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 132M +23.9M +22.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 130M +24.1M +22.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 7.37M -94.1M -92.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 108M +9.55M +9.67% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 108M +10.2M +10.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 106M +9.06M +9.31% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 101M +6.56M +6.91% Dec 31, 2021 10-K 2023-03-31
Q3 2021 98.7M +4.97M +5.3% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 97.5M +11.4M +13.2% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 97.3M +18.7M +23.8% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 94.9M +20.9M +28.2% Dec 31, 2020 10-K 2022-03-28
Q3 2020 93.7M +23.4M +33.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 86.1M +18M +26.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 78.6M +15.4M +24.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 74M +16.2M +28% Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 70.3M +14.2M +25.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 68.1M +14.2M +26.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 63.1M +10.4M +19.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 57.8M +6.85M +13.4% Dec 31, 2018 10-K 2020-03-16
Q3 2018 56.2M +5.6M +11.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 54M +3.52M +6.98% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 52.7M +2.37M +4.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 51M +2.06M +4.21% Dec 31, 2017 10-K 2019-03-18
Q3 2017 50.6M +1.71M +3.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 50.5M +1.79M +3.69% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50.3M +1.8M +3.72% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 48.9M +1.78M +3.79% Dec 31, 2016 10-K 2018-03-16
Q3 2016 48.9M +1.74M +3.7% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 48.7M +1.83M +3.92% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 48.5M +1.7M +3.63% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 47.1M +653K +1.4% Dec 31, 2015 10-K 2017-03-16
Q3 2015 47.1M +2.82M +6.37% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 46.8M +2.52M +5.69% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 46.8M +2.57M +5.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 46.5M +6.84M +17.3% Dec 31, 2014 10-K 2016-03-15
Q3 2014 44.3M +9.06M +25.7% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 44.3M +14.7M +49.7% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 44.3M +18.1M +69.1% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 39.7M +15.3M +62.5% Dec 31, 2013 10-K 2015-03-16
Q3 2013 35.3M -24.3B -99.9% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 29.6M +5.23M +21.5% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 26.2M +7.56M +40.7% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 24.4M +5.8M +31.2% Dec 31, 2012 10-K 2014-03-14
Q3 2012 24.4B +24.4B +346735% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 24.4M Jun 30, 2012 10-Q 2012-08-08
Q1 2012 18.6M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 18.6M +13.8M +288% Dec 31, 2011 10-K 2013-03-18
Q3 2011 7.03M Sep 30, 2011 10-Q 2011-11-14
Q4 2010 4.79M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.